# Scott D. Berkowitz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/scott-d-berkowitz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,005 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 70 |
| i10-index | 173 |
| Last Known Institution | I.R.C.C.S. Oasi Maria SS |
| OpenAlex ID | https://openalex.org/A5055052720 |
| ORCID iD | https://orcid.org/0000-0002-9428-4408 |
| Works | 291 |

## Researcher papers

- [Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation](https://scholariq.org/papers/rivaroxaban-versus-warfarin-in-nonvalvular-atrial-fibrillation/)
- [Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source](https://scholariq.org/papers/rivaroxaban-for-stroke-prevention-after-embolic-stroke-of-undetermined-source/)
- [Rivaroxaban in Peripheral Artery Disease after Revascularization](https://scholariq.org/papers/rivaroxaban-in-peripheral-artery-disease-after-revascularization/)
- [Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-coronary-artery/)
- [Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial](https://scholariq.org/papers/rivaroxaban-compared-with-standard-anticoagulants-for-the-treatment-of-acute/)
- [Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF](https://scholariq.org/papers/cause-of-death-and-predictors-of-all-cause-mortality-in-anticoagulated-patients/)
- [Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial](https://scholariq.org/papers/rivaroxaban-or-aspirin-for-patent-foramen-ovale-and-embolic-stroke-of/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)

## Researcher university

- [I.R.C.C.S. Oasi Maria SS](https://scholariq.org/institutions/i-r-c-c-s-oasi-maria-ss/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
